Verastem Oncology (NASDAQ: VSTM) has recently announced positive updated safety and efficacy results from the ramp 205 phase 1/2 trial, which is evaluating avutometinib plus defactinib in combination ...

An international study has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients with the therapies ...

This revision follows the commencement of a new Olympic Cycle post-Paris Olympics 2024, meeting in mind India’s aspirations ...

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute ...

Belvidere, New Jersey, U.S.A.-based sustainable agriculture company Edible Garden has acquired assets – including ...

Tempus' FDA-approved xT CDx test is being used as an investigational assay in Verastem's global Phase 3 RAMP-301 clinical trial.

Scientists at F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have identified macrocyclic compounds acting as GTPase KRAS (G12D mutant) and/or (G13D mutant) inhibitors reported to be useful for ...

The FDA has approved new agents in ovarian cancer and non–small cell lung cancer and paved the way for novel antibody-drug conjugate developments.

No. 2-ranked defending state champion Wheaton co-op was going to have its work cut out if it was going to topple No.1 Glenbard West Saturday afternoon at the second annual IHSGCA boys state ...

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...